Page 28 - GPD-2-3
P. 28

Gene & Protein in Disease                                           Signatures construction strategies for TC



                                                               of methylation in the  clinical  prognosis of TC has been
                   References  Chen et al.,   2020 [78]  Li et al.,   2019 [28]  widely recognized [64,65] . In strategy 3, these studies
                                                               included not only methylation-driven genes  but also
                                                                                                    [47]
                                                                                        .  In  particular,  regulators
                                                               regulators  of  methylation
                                                                                    [48,49,66]
                                                               of m6A RNA methylation were considered important
                   Multivariate Cox   regression analysis  P‑value  95%   HR  CI  P = 0.019  1.09 –   1.79  2.94  P < 0.001  5.94 –   29.05*  142.074  risk predictors [48,49,66] . Through comprehensive analysis,
                                                               the steps to build these signatures were as follows:
                                                               (1) transcriptome, methylation data, and relevant clinical
                                                               information were downloaded from databases, and
                                                               samples contained both tumor and normal tissues; (2) the
                                                               key methylation-driven genes or regulators of methylation


                                                               were constructed by function enrichment analyses
                                                                                                             ;
                                                                                                          [47,66]
                   Univariate Cox   regression analysis  P‑value  95%   HR  CI  P =   1.52 –   2.13  0.00001  2.99  P < 0.001  10.231 –   50.097*  245.312  were screened through various analyses; (3) signatures
                                                               and (4) Cox regression analysis, ROC, and survival curve
                                                               were applied to verify the prognostic capabilities of these
                                                               signatures. The flow chart of strategy 3 is shown in Figure 5
                                                               and the summarized relevant information of strategy 3 is
                                                                 In detail, based on methylation-driven genes, Lv
                   AUC of   the ROC   curve  1-, 3- and   5-year   AUCs:   0.731,0.746   and 0.766  AUC of 3,5   and 10-year   survival   rates:   0.948,0.965   and 0.949  presented in Table 3.  [47]
                                                               et al. constructed a 4-gene signature composed of RDH5,
                                                               BIRC7, TREM1, and SLC26A7 . Transcriptome data from
                                                               567 samples and DNA methylation data from 570 samples
                   Risk score  Risk score=   −5.367*cg17749033   + 1.619*cg24221648   + 2.334*cg01664864   + 1.873 *cg09578568   − 3.486*cg24051057   + 5.693*cg05972352  EpiLncPM = 13.1 *   AP006248.2 + 2.53 *   AC068580.3 + 33.2 *   AC016396.2 + 3.12 *   LINC01140 + 1.19 *   LINC01135 Abbreviations: TC: Thyroid cancer; PTC: Papillary thyroid cancer; DTC: Differentiated thyroid cancer; WDTC: Well-differentiated thyroid cancer; OS: Overall survival; RFS: Recurrence-free  s
                                                               (46  hypermethylation  and  5  hypomethylation)  using
                                                               “MethylMix” and “limma” R package. In addition, after Cox
                                                               regression analysis, the methylation-driven gene signature
                                                               was established and validated by the Kaplan-Meier survival

                   Survival curve  P‑value  Cut‑off   P = 0.0001  The   median   risk score  P < 0.001  The   optimal   risk   cutoff   point  curve, certifying that patients in the high-risk group
                                                               presented  a  worse  prognosis .  Besides,  Xu  et al.,  Hou
                                                                                       [47]
                                                               et al., and Wang et al. also discovered that the m6A RNA
                                                               methylation regulators have a high-risk evaluation potency.
                   Survival   event  RFS  OS                   Xu et al. and Wang et al. constructed two signatures of 4
                                                                                                  [48,66]
                                                               RNA methylation regulators, respectively
                                                                                                     , whereas
                                                               Hou et al. selected RBM15, FTO, and KIAA1429 to establish
                                                                               [49]
                                                               a 3-gene signature . By comparing the differentially
                   Signatures   outcome  Unfavorable  Unfavorable  expressed m6A RNA methylation regulators, they selected
                                                               13 RNA methylation regulators. Cox and lasso regression
                                                               analyses were applied to assess the relationship between
                   Signatures  A 6-DNA   methylation   signature   A   methylation-   driven   5-lncRNA   -based   signature   OS and these methylation regulators. Thus, this 3-gene
                                                               signature was constructed and validated.
                                                               3.3.4. Other strategies
                   Signatures   type  DNA    methylation   sites  methylation   -driven   lncRNA  prognostic signatures are associated with a worse prognosis.  In addition to the three main aforementioned strategies,
                                                               few  studies  adopted other  strategies  to identify
                                                               signatures
                                                                          , and the summarized relevant information
                                                                       [50-54]
                                                               of these strategies is presented in Table 4.
               Table 3. (Continued)  Pathological   Authors  type  PTC  Hengyu   Chen,   et al., 2020  TC  Qiuying   Li, et al.,   2020  3.3.4.1. Signatures related to glucose metabolism

                                                               Increasing evidence has demonstrated that glucose
                                                               metabolism and glucose transporters (GLUTs) play
                                                               essential roles in TC progression
                                                                                            . Suh et al. have studied
                                                                                        [67-70]

            Volume 2 Issue 3 (2023)                         12   glucose metabolism by constructing GLUT signature and
                                                                                     https://doi.org/10.36922/gpd.1138
   23   24   25   26   27   28   29   30   31   32   33